195 related articles for article (PubMed ID: 18004586)
1. Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma.
Costagliola C; Parmeggiani F; Virgili G; Lamberti G; Incorvaia C; Perri P; Campa C; Sebastiani A
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):389-96. PubMed ID: 18004586
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Effects of Dorzolamide/Timolol Fixed Combination versus Latanoprost on Intraocular Pressure and Ocular Perfusion Pressure in Patients with Normal-Tension Glaucoma: A Randomized, Crossover Clinical Trial.
Lee NY; Park HY; Park CK
PLoS One; 2016; 11(1):e0146680. PubMed ID: 26756747
[TBL] [Abstract][Full Text] [Related]
4. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
[TBL] [Abstract][Full Text] [Related]
5. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
6. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.
Liu CJ; Ko YC; Cheng CY; Chiu AW; Chou JC; Hsu WM; Liu JH
Ophthalmology; 2002 Dec; 109(12):2241-7. PubMed ID: 12466165
[TBL] [Abstract][Full Text] [Related]
7. Peak pressures: crossover study of timolol and latanoprost.
Sihota R; Saxena R; Agarwal HC; Pandey RM; Gulati V
Eur J Ophthalmol; 2003 Jul; 13(6):546-52. PubMed ID: 12948313
[TBL] [Abstract][Full Text] [Related]
8. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
Ishibashi S; Hirose N; Tawara A; Kubota T
J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
[TBL] [Abstract][Full Text] [Related]
9. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
Quaranta L; Miglior S; Floriani I; Pizzolante T; Konstas AG
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4226-31. PubMed ID: 18502991
[TBL] [Abstract][Full Text] [Related]
10. 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol.
Konstas AG; Pikilidou MI; Tsironi S; Mikropoulos D; Kozobolis VP; Sarafidis PA; Lasaridis AN; Nelson LA; Stewart WC
Curr Eye Res; 2009 May; 34(5):369-77. PubMed ID: 19401880
[TBL] [Abstract][Full Text] [Related]
11. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
[TBL] [Abstract][Full Text] [Related]
12. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
14. Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short-term studies with three dose regimens of latanoprost treatment.
Greve EL; Rulo AH; Drance SM; Crichton AC; Mills RP; Hoyng PF
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S89-92. PubMed ID: 9154282
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
16. Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension.
Larsson LI
Ophthalmology; 2001 Aug; 108(8):1439-44. PubMed ID: 11470697
[TBL] [Abstract][Full Text] [Related]
17. The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
Diestelhorst M
Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):433-9. PubMed ID: 10901475
[TBL] [Abstract][Full Text] [Related]
18. 24-Hour control with a latanoprost-timolol fixed combination vs timolol alone.
Konstas AG; Lake S; Economou AI; Kaltsos K; Jenkins JN; Stewart WC
Arch Ophthalmol; 2006 Nov; 124(11):1553-7. PubMed ID: 17102001
[TBL] [Abstract][Full Text] [Related]
19. Diurnal intraocular pressure with bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in healthy subjects.
Shim SH; Kim JM; Choi CY; Kim CY
Korean J Ophthalmol; 2014 Feb; 28(1):39-48. PubMed ID: 24505200
[TBL] [Abstract][Full Text] [Related]
20. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
